[Potentiation of antineoplastic agents--significance of combination with urokinase].
D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D001943:Breast Neoplasms / Q000188:drug therapy; D003911:Dextrans / Q000494:pharmacology; D004357:Drug Synergism; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage* / Q000494:pharmacology; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D008937:Mitomycins / Q000494:pharmacology; D012004:Rectal Neoplasms / Q000188:drug therapy; D012517:Sarcoma, Yoshida / Q000196:embryology; D013160:Splenic Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy
D000970:Antineoplastic Agents; D003911:Dextrans; D005343:Fibrinolytic Agents; D008937:Mitomycins; D005340:Fibrinogen